Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis.
Social and economic burden of walking and mobility problems in multiple sclerosis.
Assessment of postural stabilization in three task oriented movements in people with multiple sclerosis.
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.
Statin treatment of adult human glial progenitors induces PPAR gamma-mediated oligodendrocytic differentiation.
Novel Kv1.3 blockers for immunosuppression: W02012155199.
Sphingosine-1-phosphate in chronic intestinal inflammation and cancer.
Alemtuzumab for relapsing-remitting multiple sclerosis.
Developing a therapeutic plan for treating MS: evidence for new treatments.
Decrease in levels of the evolutionarily conserved microRNA miR-124 affects oligodendrocyte numbers in Zebrafish, Danio rerio.
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
Acute Disseminated Encephalomyelitis: The Time Until Diagnosis and Its Subsequent Course in Children.
Selection and optimization of therapy for progressive type multiple sclerosis.
Diffusion tensor imaging of extraocular muscle using two-dimensional single-shot interleaved multiple inner volume imaging diffusion-weighted EPI at 3 tesla.
Neuropathic pain in animal models of nervous system autoimmune diseases.
Targeting CXCL13 During Neuroinflammation.
Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence.
Bouncing back again, and again: a qualitative study of resilience in people with multiple sclerosis.
Analysis of prognostic factors associated with longitudinally extensive transverse myelitis.
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.
Perivascular spaces in MS patients at 7 Tesla MRI: A marker of neurodegeneration?
Cervical dysplasia associated with the use of natalizumab.
Age of Onset as a Moderator of Cognitive Decline in Pediatric-Onset Multiple Sclerosis.
LEBER'S DISEASE WITH SYMPTOMS RESEMBLING DISSEMINATED SCLEROSIS.

Pages